ABELCET (Sigma-Tau Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the ABELCET drug offered from Sigma-Tau Pharmaceuticals, Inc.. This Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sigma-Tau Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- |
SUBSTANCE NAME: | AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL- |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-10-18 |
END MARKETING DATE: | 0000-00-00 |
ABELCET HUMAN PRESCRIPTION DRUG Details:
Item Description | ABELCET from Sigma-Tau Pharmaceuticals, Inc. |
LABELER NAME: | Sigma-Tau Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 3.4; 1.5(mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2010-10-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57665-101_517c742b-dbcc-4f39-878c-b5a1d6536fe0 |
PRODUCT NDC: | 57665-101 |
APPLICATION NUMBER: | NDA050724 |
Other AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL- Pharmaceutical Manufacturers / Labelers: